Crossmark

TMEM52B-derived peptides inhibit generation of soluble E-cadherin and EGFR activity to suppress colon cancer growth and early metastasis

Published Online: 2025-03-03

Authors

Lee, Yunhee

Ko, Dongjoon

Yoon, Junghwa

Kim, Semi https://orcid.org/0000-0001-8043-1465
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2023R1A2C1006554)

National Research foundation of Korea (2022R1A6A3A01086020)
License Information

Text and Data Mining valid from 2025-03-03

Version of Record valid from 2025-03-03
More Information

Article History

Received: 27 August 2024

Accepted: 2 January 2025

First Online: 3 March 2025

Declarations

:

: The animal study was performed in accordance with the guidelines of the Animal Care Committee at the Korea Research Institute of Bioscience and Biotechnology (KRIBB), and with approval of the bioethics committee of the KRIBB (KRIBB-AEC-22107).

: Not applicable.

: The authors declare no competing interests.

Document is current